Anaptys Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

Anaptys (Nasdaq: ANAB) announced that its CEO Daniel Faga and other executives will participate in multiple investor conferences in February–March 2026, including Guggenheim, Piper Sandler, TD Cowen, Barclays, UBS, and Leerink.

Live fireside chats and 1x1 meetings are scheduled; webcasts will be available on the company's investor website with replays for at least 30 days.

News Market Reaction

-0.99%

4 alerts

-0.99% News Effect

+11.6% Peak Tracked

-$14M Valuation Impact

$1.43B Market Cap

1.3x Rel. Volume

On the day this news was published, ANAB declined 0.99%, reflecting a mild negative market reaction. Argus tracked a peak move of +11.6% during that session. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $1.43B at that time.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:

Guggenheim Emerging Outlook: Biotech Summit 2026, New York, NY

• Format – Fireside chat and 1x1 investor meetings
• Date and Time – Wednesday, Feb. 11, 2026 at 3:00pm ET

Piper Sandler Virtual Novel Targets in Immunology Symposium, Virtual

• Format – Fireside chat
• Date and Time – Thursday, Feb. 12, 2026 at 12:30pm ET

TD Cowen 46th Annual Health Care Conference, Boston, MA

• Format – Fireside chat and 1x1 investor meetings
• Date and Time – Wednesday, Mar. 4, 2026 at 11:50am ET

Barclays 28th Annual Global Healthcare Conference, Miami, FL

• Format – Fireside chat and 1x1 investor meetings
• Date and Time – Tuesday, Mar. 10, 2026 at 8:30am ET

UBS Biotech Summit Miami: Catalyst for Change, Miami, FL

• Format –1x1 investor meetings
• Date and Time – Tuesday, Mar. 10, 2026 
  

Leerink Global Healthcare Conference, Miami FL

• Format – Fireside chat and 1x1 investor meetings
• Date and Time – Wednesday, Mar. 11, 2026 at 2:20pm ET
  

Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. Replays of the webcasts will be available for at least 30 days following the events.

About Anaptys

Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The company’s pipeline includes rosnilimab, a pathogenic T cell depleter, which has completed a Phase 2b trial for rheumatoid arthritis; ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease and eosinophilic esophagitis; and ANB101, a BDCA2 modulator, in a Phase 1a trial. Anaptys has also discovered and out-licensed in financial collaborations multiple therapeutic antibodies, including a PD-1 antagonist (Jemperli (dostarlimab-gxly)) to GSK and an IL-36R antagonist (imsidolimab) to Vanda Pharmaceuticals. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.

Anaptys recently announced the intent to separate its biopharma operations from its substantial royalty assets by year-end 2026, enabling investors to align their investment philosophies and portfolio allocation with the strategic opportunities and financial objectives of each company. Learn more here.

Contact:
Nick Montemarano
Executive Director, Investor Relations
858.732.0178
investors@anaptysbio.com

FAQ

When will Anaptys (ANAB) present at the Guggenheim Emerging Outlook: Biotech Summit 2026?

Anaptys will present on Wednesday, Feb. 11, 2026 at 3:00pm ET. According to Anaptys, Daniel Faga or other executives will appear in a fireside chat and hold 1x1 investor meetings at the New York event.

How can investors watch Anaptys (ANAB) fireside chats for the Piper Sandler virtual symposium?

Investors can watch the Piper Sandler fireside chat via a live webcast on the company's investor site at the scheduled time. According to Anaptys, the virtual event is on Thursday, Feb. 12, 2026 at 12:30pm ET.

What are Anaptys (ANAB) participation details for TD Cowen 46th Annual Health Care Conference?

Anaptys is scheduled for a fireside chat and 1x1 meetings on Wednesday, Mar. 4, 2026 at 11:50am ET. According to Anaptys, executives will attend the Boston conference and provide investor-facing presentations.

Which March 2026 Miami conferences will Anaptys (ANAB) attend and when?

Anaptys plans to attend Barclays, UBS, and Leerink events in Miami on Mar. 10–11, 2026, with meetings and fireside chats. According to Anaptys, formats include 1x1 investor meetings and fireside chats across those dates.

Will Anaptys (ANAB) provide webcasts and replays of its conference presentations?

Yes. Live webcasts of the fireside chats will be available on the investor section of the company website, with replays available for at least 30 days. According to Anaptys, investors can access presentations at the listed IR presentations page.

Who from Anaptys (ANAB) will represent the company at the investor conferences?

Daniel Faga, president and CEO, and/or other members of executive leadership are scheduled to participate. According to Anaptys, company executives will conduct fireside chats and 1x1 investor meetings at the listed conferences.